Skip to main content
ImmuneCited

Vitamin D için Immune Aging (Immunosenescence)

B Kanıt Bunu büyük ölçüde tutarlı sonuçlarla en az bir randomize çalışma desteklemektedir.

Research suggests vitamin D supplementation in elderly populations may help improve immune markers and vaccine response. Deficiency is highly prevalent in older adults and is associated with impaired immune function and increased infection susceptibility.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dimmunosenescence'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Sonuç

Research suggests vitamin D supplementation in elderly populations may help improve immune markers and vaccine response. Deficiency is highly prevalent in older adults and is associated with impaired immune function and increased infection susceptibility.

Key Study Findings

Review
Fanconi anaemia as a human model of accelerated epigenetic and immune ageing.
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: patients with Fanconi anaemia

Randomized Controlled Trial n=124
Effects of a Novel Dispersible Supplement Containing 2500 IU of Vitamin D and 1000 µg …
Dose: 2500 IU vitamin D + 1000 mcg B12 vs: Separate D+B12 and no supplementation control Outcome: Serum 25-OH-D and B12 level restoration Etki: 37.1% adequate vs 29.4% separate None

Popülasyon: Adults with vitamin D (<20ng/mL) and B12 (<250ng/L) insufficiency

Observational Study n=72
Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study.
Dose: None vs: Healthy controls Outcome: CVR and systemic inflammation in alopecia areata Etki: None None

Popülasyon: 36 AA patients vs 36 matched controls, mean age 39

Controlled Clinical Trial
Vitamin D stimulates Il-15 synthesis in rodent muscle.
Dose: Single dose (rats); variable (in vitro) vs: Untreated controls; VDR-KO mice Outcome: IL-15 gene expression in skeletal muscle Etki: None None

Popülasyon: C2C12 myotubes, rats, VDR-KO mice

Randomized Controlled Trial 8 weeks
Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus …
Dose: Topical ointment application (3 arms) vs: 3-arm: mometasone vs calcipotriol vs tacrolimus Outcome: SALT score change at 8 weeks Etki: None <0.001 (momet, calcipot)

Popülasyon: Patients with localized alopecia areata

Other
Modelling the influence of vitamin D and probiotics on inflammation and the intestinal microbiota in …
Dose: None vs: No supplementation (modeled) Outcome: Epithelial barrier integrity and immune response Etki: None None

Popülasyon: Older adults (mathematical model)

Key Statistics

10

Çalışmalar

5000

Katılımcılar

Positive

B

Derece

Referenced Papers

Biochemistry and biophysics … 2025
International journal of … 2023 54 atıf
Autoimmunity reviews 2023 24 atıf
Physiological research 2021 2 atıf
Advances in chronic … 2019 326 atıf
Actas dermo-sifiliograficas 2019 43 atıf
Postepy dermatologii i … 2017 31 atıf
World journal of … 2016 238 atıf
Ageing research reviews 2016 142 atıf
Postepy dermatologii i … 2016 59 atıf
Indian dermatology online … 2016 51 atıf
World journal of … 2015 62 atıf
The American journal … 2014 125 atıf
European journal of … 2012 225 atıf
Inflammatory bowel diseases 2012 224 atıf
Gerontology 2011 27 atıf
Gastroenterology 2010 390 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
600-800 IU/day
immunesupport:
1,000-2,000 IU/day
deficiencycorrection:
4,000-5,000 IU/day (under medical supervision)

Üst sınır: 4,000 IU/day (100 mcg)

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Negative --
2500 IU vitamin D + 1000 mcg B12 -- Positive 124
None -- Negative 72
Single dose (rats); variable (in vitro) -- Positive --
Topical ointment application (3 arms) 8 weeks Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --

En iyi alım zamanı: With a meal containing fat for better absorption

Safety & Side Effects

Bildirilen Yan Etkiler

  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones with excessive long-term use
  • Constipation
  • Metallic taste

Bilinen Etkileşimler

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

Tolere edilebilir üst alım: 4,000 IU/day (100 mcg)

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Vitamin D help with Immune Aging (Immunosenescence)?
Based on 10 studies with 5,000 participants, there is moderate evidence from clinical studies that Vitamin D may support Immune Aging (Immunosenescence) management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for Immune Aging (Immunosenescence)?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Immune Aging (Immunosenescence)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 5,000 total participants. The overall direction of effect is positive.

References

  1. [1] Eunike Velleuer et al.. Ageing Res Rev. 2026. Fanconi anaemia as a human model of accelerated epigenetic and immune ageing. doi:10.1016/j.arr.2026.103038 PubMed
  2. [2] Hammad Ullah. Immun Ageing. 2025. Gut-vitamin D interplay: key to mitigating immunosenescence and promoting healthy ageing. doi:10.1186/s12979-025-00514-y PubMed
  3. [3] Erick Alejandro Jiménez-Herrera et al.. Skin Appendage Disord. 2025. Vitamin D and Alopecia Areata: From Mechanism to Therapeutic Implications. doi:10.1159/000545711 PubMed
  4. [4] Tiziana Galeazzi et al.. Nutrients. 2025. Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do? doi:10.3390/nu17091425 PubMed
  5. [5] Samira Rastgoo et al.. Front Immunol. 2025. Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. doi:10.3389/fimmu.2025.1570441 PubMed
  6. [6] Ghadah Alhetheli et al.. Clin Cosmet Investig Dermatol. 2025. Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata. doi:10.2147/CCID.S504475 PubMed
  7. [7] Farheen Begum et al.. Indian Dermatol Online J. 2025. Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with … doi:10.4103/idoj.idoj_913_23 PubMed
  8. [8] Laura Cianfruglia et al.. Biogerontology. 2025. Cytomegalovirus (CMV), oxidative stress, and inflammation: implications for immunosenescence and age-related diseases in the MARK-AGE population. doi:10.1007/s10522-025-10288-x PubMed
  9. [9] Susan Franks et al.. Sci Rep. 2025. Modelling the influence of vitamin D and probiotics on inflammation and the intestinal microbiota in older adults. doi:10.1038/s41598-025-26132-8 PubMed
  10. [10] Franz Ewendt et al.. Biochem Biophys Rep. 2025. Vitamin D stimulates Il-15 synthesis in rodent muscle. doi:10.1016/j.bbrep.2025.101925 PubMed
  11. [11] Alberto Soto-Moreno et al.. Acta Dermatovenerol Croat. 2025. Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study. PubMed
  12. [12] Lisha Jeena et al.. AIDS. 2025. The effects of HIV on bone and muscle health through the lifespan in populations living in Africa. doi:10.1097/QAD.0000000000004307 PubMed
  13. [13] Samira Rastgoo et al.. Front Immunol. 2025. Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical … doi:10.3389/fimmu.2025.1627178 PubMed
  14. [14] Nikolaos Angelopoulos et al.. Nutrients. 2025. Effects of a Novel Dispersible Supplement Containing 2500 IU of Vitamin D and 1000 µg of B12 in Restoring Vitamin … doi:10.3390/nu17030419 PubMed
  15. [15] Bhavani Sowndharya Balamurugan et al.. Immun Ageing. 2024. Micro nutrients as immunomodulators in the ageing population: a focus on inflammation and autoimmunity. doi:10.1186/s12979-024-00492-7 PubMed
  16. [16] Siddhi B Chikhalkar et al.. Indian Dermatol Online J. 2024. Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata. doi:10.4103/idoj.idoj_535_23 PubMed
  17. [17] Victoria Birlutiu et al.. Pharmaceuticals (Basel). 2024. Identification of Factors Associated with Mortality in the Elderly Population with SARS-CoV-2 Infection: Results from a Longitudinal Observational Study from … doi:10.3390/ph17020202 PubMed
  18. [18] Maha H Ragaie et al.. J Cosmet Laser Ther. 2024. Intralesional vitamin D3 versus intralesional triamcinolone acetonoid in patchy alopecia areata: a comparative clinical and dermoscopic study. doi:10.1080/14764172.2024.2389275 PubMed
  19. [19] Kitty St Pierre et al.. Cochrane Database Syst Rev. 2024. Interventions for preventing the progression of autosomal dominant polycystic kidney disease. doi:10.1002/14651858.CD010294.pub3 PubMed
  20. [20] Cristina Fantini et al.. Int J Mol Sci. 2023. Vitamin D as a Shield against Aging. doi:10.3390/ijms24054546 PubMed
  21. [21] Hanane Touil et al.. Front Immunol. 2023. Differential impact of environmental factors on systemic and localized autoimmunity. doi:10.3389/fimmu.2023.1147447 PubMed
  22. [22] Hiba Zaaroura et al.. Autoimmun Rev. 2023. Biomarkers in alopecia Areata: A systematic review and meta-analysis. doi:10.1016/j.autrev.2023.103339 PubMed
  23. [23] Yilan Zeng et al.. Mini Rev Med Chem. 2023. The Role of VD/VDR Signaling Pathway in Autoimmune Skin Diseases. doi:10.2174/1389557523666221124123206 PubMed
  24. [24] Marcelo Henrique Reis Caldeira et al.. Gerontology. 2023. Immune Profile and Body Composition of Independent Oldest Old: The Longevous Project. doi:10.1159/000527485 PubMed
  25. [25] Fatemeh Mokhtari et al.. J Cosmet Dermatol. 2023. Inverse correlation between vitamin D and CRP levels in alopecia areata: A pilot study. doi:10.1111/jocd.15994 PubMed
  26. [26] Elham Hamidpour et al.. Health Sci Rep. 2023. Effects of age and sex on the comorbidities of alopecia areata: A cross-sectional hospital-based study. doi:10.1002/hsr2.1444 PubMed
  27. [27] Manisha Singh Basukala et al.. J Nepal Health Res Counc. 2023. Determination of Serum 25-Hydroxyvitamin D Levels in Patients with Alopecia Areata. doi:10.33314/jnhrc.v20i3.4408 PubMed
  28. [28] Amira Fathy Rashad et al.. J Cosmet Dermatol. 2022. Intralesional vitamin D3 in treatment of alopecia areata: A randomized controlled clinical trial. doi:10.1111/jocd.14844 PubMed
  29. [29] Qin Feng et al.. Front Immunol. 2022. The Aging Features of Thyrotoxicosis Mice: Malnutrition, Immunosenescence and Lipotoxicity. doi:10.3389/fimmu.2022.864929 PubMed
  30. [30] Yamei Gao et al.. J Cosmet Dermatol. 2022. Evaluation of several immune and inflammatory indicators and their association with alopecia areata. doi:10.1111/jocd.14504 PubMed
  31. [31] Mariane Lutz et al.. Rev Esp Geriatr Gerontol. 2022. [Immunosenescence, viral infections and nutrition: A narrative review of scientific available evidence]. doi:10.1016/j.regg.2021.08.003 PubMed
  32. [32] Sule Goksin. North Clin Istanb. 2022. Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata. doi:10.14744/nci.2022.78790 PubMed
  33. [33] Davide Chesini Ms et al.. J Diet Suppl. 2022. Vitamin B12 and Atopic Dermatitis: Any Therapeutic Relevance For Oral Supplementation? doi:10.1080/19390211.2020.1860180 PubMed
  34. [34] Patrick Thanh Tran et al.. Int J Trichology. 2022. Vitamin D Levels in Alopecia Areata and Other Alopecias: A Retrospective Case- Control Study at a Single Institution. doi:10.4103/ijt.ijt_131_20 PubMed
  35. [35] Sapna P Sadarangani et al.. NPJ Vaccines. 2022. DYNAMIC cohort study evaluating metabolic predictors of influenza vaccine immune response in older adults. doi:10.1038/s41541-022-00548-z PubMed
  36. [36] Philip C Calder et al.. Adv Nutr. 2022. Nutrition, Immunosenescence, and Infectious Disease: An Overview of the Scientific Evidence on Micronutrients and on Modulation of the Gut Microbiota. doi:10.1093/advances/nmac052 PubMed
  37. [37] Ahmed Al Saedi et al.. BMJ Open. 2022. Effects of 3 months of multi-nutrient supplementation on the immune system and muscle and respiratory function of older adults in … doi:10.1136/bmjopen-2021-059075 PubMed
  38. [38] Petra Zimmermann et al.. Arch Dis Child. 2021. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of … doi:10.1136/archdischild-2020-320338 PubMed
  39. [39] Sooyeon Oh et al.. Front Immunol. 2021. Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific. doi:10.3389/fimmu.2021.594356 PubMed
  40. [40] L Kapustova et al.. Physiol Res. 2021. COVID-19 and the differences in physiological background between children and adults and their clinical consequences. doi:10.33549/physiolres.934759 PubMed
  41. [41] Basak Yalici-Armagan et al.. Int J Clin Pract. 2021. Paediatric lichen sclerosus et atrophicus: A retrospective analysis of 38 paediatric patients. doi:10.1111/ijcp.14661 PubMed
  42. [42] Dimitrios T Papadimitriou et al.. World J Clin Pediatr. 2021. Treatment of alopecia totalis/universalis/focalis with vitamin D and analogs: Three case reports and a literature review. doi:10.5409/wjcp.v10.i6.192 PubMed
  43. [43] Giovanna Borriello et al.. Int J Environ Res Public Health. 2021. Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients. doi:10.3390/ijerph18147338 PubMed
  44. [44] Felix Paolo J Lizarondo et al.. JAAD Int. 2021. Determination of serum 25-hydroxyvitamin D levels in patients with alopecia areata and their comparison with levels in healthy controls: A … doi:10.1016/j.jdin.2021.07.008 PubMed
  45. [45] L Máčová et al.. Physiol Res. 2021. Endocrine risk factors for COVID-19 in context of aging. doi:10.33549/physiolres.934723 PubMed
  46. [46] Ben Kirk et al.. J Cachexia Sarcopenia Muscle. 2020. Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers. doi:10.1002/jcsm.12567 PubMed
  47. [47] Carroll A Reider et al.. Nutrients. 2020. Inadequacy of Immune Health Nutrients: Intakes in US Adults, the 2005-2016 NHANES. doi:10.3390/nu12061735 PubMed
  48. [48] Sushil K Jain et al.. J Am Coll Nutr. 2020. Can Vitamin D and L-Cysteine Co-Supplementation Reduce 25(OH)-Vitamin D Deficiency and the Mortality Associated with COVID-19 in African Americans? doi:10.1080/07315724.2020.1789518 PubMed
  49. [49] Elisa Molinelli et al.. Dermatol Ther (Heidelb). 2020. Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot … doi:10.1007/s13555-020-00379-7 PubMed
  50. [50] Rajesh Parsanathan et al.. Nutrients. 2020. l-Cysteine and Vitamin D Co-Supplementation Alleviates Markers of Musculoskeletal Disorders in Vitamin D-Deficient High-Fat Diet-Fed Mice. doi:10.3390/nu12113406 PubMed
  51. [51] Maaz Syed-Ahmed et al.. Adv Chronic Kidney Dis. 2019. Immune Dysfunction and Risk of Infection in Chronic Kidney Disease. doi:10.1053/j.ackd.2019.01.004 PubMed
  52. [52] Nicolas Goncalves-Mendes et al.. Front Immunol. 2019. Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial. doi:10.3389/fimmu.2019.00065 PubMed
  53. [53] T Tannou et al.. Med Mal Infect. 2019. Multifactorial immunodeficiency in frail elderly patients: Contributing factors and management. doi:10.1016/j.medmal.2019.01.012 PubMed
  54. [54] Xiran Lin et al.. Am J Transl Res. 2019. Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy. PubMed
  55. [55] F J Navarro-Triviño et al.. Actas Dermosifiliogr (Engl Ed). 2019. Vitamin D and the Skin: A Review for Dermatologists. doi:10.1016/j.ad.2018.08.006 PubMed
  56. [56] Harsha Siddappa et al.. Indian Dermatol Online J. 2019. Evaluation of Association of Vitamin D in Alopecia Areata: A Case-control Study of 100 Patients in a Tertiary Rural Hospital … doi:10.4103/idoj.IDOJ_84_18 PubMed
  57. [57] Hans-Klaus Goischke. Ther Clin Risk Manag. 2019. Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis. doi:10.2147/TCRM.S188941 PubMed
  58. [58] Adit A Ginde et al.. J Am Geriatr Soc. 2017. High-Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial. doi:10.1111/jgs.14679 PubMed
  59. [59] Munkyong Pae et al.. Nutr Res. 2017. Nutritional modulation of age-related changes in the immune system and risk of infection. doi:10.1016/j.nutres.2017.02.001 PubMed
  60. [60] C M R Gonçalves de Carvalho et al.. Eur J Clin Nutr. 2017. Aging, low-grade systemic inflammation and vitamin D: a mini-review. doi:10.1038/ejcn.2016.177 PubMed
  61. [61] Seval Erpolat et al.. Postepy Dermatol Alergol. 2017. 25-hydroxyvitamin D status in patients with alopecia areata. doi:10.5114/ada.2017.67847 PubMed
  62. [62] Danuta Owczarek et al.. World J Gastroenterol. 2016. Diet and nutritional factors in inflammatory bowel diseases. doi:10.3748/wjg.v22.i3.895 PubMed
  63. [63] Carla Domingues-Faria et al.. Ageing Res Rev. 2016. Skeletal muscle regeneration and impact of aging and nutrition. doi:10.1016/j.arr.2015.12.004 PubMed
  64. [64] Ebru Karagün et al.. Postepy Dermatol Alergol. 2016. The role of serum vitamin D levels in vitiligo. doi:10.5114/pdia.2016.59507 PubMed
  65. [65] Ola Ahmed Bakry et al.. Indian Dermatol Online J. 2016. Serum Vitamin D in patients with alopecia areata. doi:10.4103/2229-5178.190504 PubMed
  66. [66] Wolfgang Kruis et al.. Dig Dis. 2016. Iron Deficiency, Zinc, Magnesium, Vitamin Deficiencies in Crohn's Disease: Substitute or Not? doi:10.1159/000443012 PubMed
  67. [67] Sapna P Sadarangani et al.. Hum Vaccin Immunother. 2016. Vitamin D, leptin and impact on immune response to seasonal influenza A/H1N1 vaccine in older persons. doi:10.1080/21645515.2015.1097015 PubMed
  68. [68] Omar A Masri et al.. World J Gastroenterol. 2015. Role of vitamins in gastrointestinal diseases. doi:10.3748/wjg.v21.i17.5191 PubMed
  69. [69] Aslı Aksu Çerman et al.. J Drugs Dermatol. 2015. Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study. PubMed
  70. [70] Naglaa Hani El-Abbadi et al.. Am J Clin Nutr. 2014. Yogurt: role in healthy and active aging. doi:10.3945/ajcn.113.073957 PubMed
  71. [71] Neha R Santucci et al.. J Pediatr Gastroenterol Nutr. 2014. Vitamin and zinc status pretreatment and posttreatment in patients with inflammatory bowel disease. doi:10.1097/MPG.0000000000000477 PubMed
  72. [72] Roberto d'Ovidio et al.. Dermatoendocrinol. 2013. Reduced level of 25-hydroxyvitamin D in chronic/relapsing Alopecia Areata. doi:10.4161/derm.24411 PubMed
  73. [73] Yong Gil Hwang et al.. Adv Aging Res. 2013. Increased vitamin D is associated with decline of naïve, but accumulation of effector, CD8 T cells during early aging. doi:10.4236/aar.2013.22010 PubMed
  74. [74] Cheng-Lin Lang et al.. EPMA J. 2013. Altered molecular repertoire of immune system by renal dysfunction in the elderly: is prediction and targeted prevention in the horizon? doi:10.1186/1878-5085-4-17 PubMed
  75. [75] Nils Hovdenak et al.. Eur J Obstet Gynecol Reprod Biol. 2012. Influence of mineral and vitamin supplements on pregnancy outcome. doi:10.1016/j.ejogrb.2012.06.020 PubMed
  76. [76] Caroline Hwang et al.. Inflamm Bowel Dis. 2012. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. doi:10.1002/ibd.22906 PubMed
  77. [77] Susanne C Diesner et al.. Gerontology. 2011. Food allergy: only a pediatric disease? doi:10.1159/000279756 PubMed
  78. [78] E Crétel et al.. Rev Med Interne. 2011. [Immune profile of elderly patients admitted in a geriatric short care unit]. doi:10.1016/j.revmed.2010.10.002 PubMed
  79. [79] Andrew T Chan et al.. Gastroenterology. 2010. Primary prevention of colorectal cancer. doi:10.1053/j.gastro.2010.01.057 PubMed
  80. [80] Linda A Linday. J Am Coll Nutr. 2010. Cod liver oil, young children, and upper respiratory tract infections. doi:10.1080/07315724.2010.10719894 PubMed
  81. [81] Miriam Capri et al.. Artif Organs. 2006. Complexity of anti-immunosenescence strategies in humans. doi:10.1111/j.1525-1594.2006.00295.x PubMed
  82. [82] Wiebke Arlt et al.. Aging Cell. 2004. Hormones and immune function: implications of aging. doi:10.1111/j.1474-9728.2004.00109.x PubMed
  83. [83] E Y Enioutina et al.. Vaccine. 2000. Enhancement of common mucosal immunity in aged mice following their supplementation with various antioxidants. doi:10.1016/s0264-410x(00)00008-6 PubMed

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.